References and Notes
1 Yang G.-L. inventors; CN 200710301577.6.
2
Prakash O.
Bhardwaj V.
Kumar R.
Tyagi P.
Aneja
KR.
Eur.
J. Med. Chem.
2004,
39:
1073
3
Bradbury RH.
Major OS.
Oldham AA.
Rivett JE.
Roberts DA.
Slater AM.
Timms D.
Waterson D.
J.
Med. Chem.
1990,
33:
2335
4
Babichev FS.
Kovtunenko VA.
Khim. Geterotsikl. Soedin.
1977,
147
5
Allen CFH.
Beilfuss HR.
Burness DM.
Reynolds GA.
Tinker JF.
Van Allan JA.
J. Org. Chem.
1959,
24:
787
6
Kottke K.
Kuhmstedt K.
Knoke D.
Pharmazie
1983,
38:
25
7
El-Sherief HA.
Abdel-Rachman AE.
El-Naggar GM.
Mahmoud AM.
Bull.
Chem. Soc. Jpn.
1983,
56:
1227
8
Bower JD.
Doyle FP.
J. Chem. Soc.
1957,
727
9
Oganisyan ASh.
Noravyan AS.
Karapetyan AA.
Aleksanyan MS.
Struchkov YuT.
Khim. Geterotsikl. Soedin.
2004,
85
10
Lalezari I.
Jabari-Sahbari MH.
J. Heterocycl.
Chem.
1978,
15:
873
11
Vas’kevich RI.
Savitskii PV.
Zborovskii YuL.
Staninets VI.
Rusanov EB.
Chernega AN.
Russ. J. Org. Chem.
2006,
42:
1403
12
Zhang Z.-T.
Tan D.-J.
Xue D.
HeIv.
Chim. Acta
2007,
90:
2096
13
Zhang Z.-T.
Xu F.-F.
Gao M.-X.
Qiu L.
J. Comb. Chem.
2009,
11:
880
14
Zhang Z.-T.
Qiu L.
Xue D.
Wu J.
Xu F.-F.
J. Comb. Chem.
2010,
12:
225
15
Lidstrom P.
Tierney J.
Wathey B.
Westman J.
Tetrahedron
2001,
57:
9225
16
Mingos DMP.
Baghurst DR.
Chem.
Soc. Rev.
1991,
20:
1
17
Abramovitch RA.
Org.
Prep. Proced. Int.
1991,
23:
683
18
6-Phenyl-7-(2-hydroxy-4-isopropoxyphenyl)[1,2,4]-triazolo[4,3-
a
]pyrimidine (3a)
Mp 228-230 ˚C.
IR (KBr): ν = 3083, 2982, 2679, 2586, 1610, 1504,
1440, 1381, 1292, 1264, 1180, 1115, 989, 921, 846, 791, 757, 703,
652, 573, 506, 461 cm-¹. ¹H
NMR (300 MHz, DMSO-d
6): δ = 1.26
(d, J = 5.9
Hz, 6 H), 4.56 (m, 1 H), 6.39 (d, J = 8.2
Hz, 2 H), 7.03 (d, J = 8.2
Hz, 1 H), 7.33 (m, 5 H), 8.60 (s, 1 H), 8.95 (s, 1 H), 9.86 (s,
1 H) ppm.
¹³C NMR (75 MHz,
DMSO-d
6): δ = 21.8,
69.4, 102.6, 106.4, 118.7, 125.0, 127.8, 128.3, 129.4, 131.6, 134.4,
144.2, 154.3, 155.5, 155.9, 156.9, 160.2 ppm. MS (EI): m/z (rel intensity) = 369
(62) [M + Na], 347 (100) [M + 1],
305 (66). Anal. Calcd for C20H18N4O2:
C, 69.35; H, 5.24; N, 16.17. Found: C, 69.18; H, 5.31; N, 16.25.
19
Representative
Procedure for the Preparation of 6-Phenyl-7-(2-hydroxy-4-isopropoxy-phenyl)[1,2,4]-triazolo[4,3-
a
]-pyrimidine (3a) and 3-Hydroxy-6-phenyl-7-(2-hydroxy-4-isopropoxyphenyl)[1,2,4]triazolo[4,3-
a
]pyrimidine (3s)
The ipriflavone (1a, 1.5 mmol, 420 mg), 2a (2.1
mmol, 118 mg) and NaOMe (4.5 mmol, 3 equiv) were mixed in DMSO (8
mL). The mixture was heated by the microwave irradiation (output
240 W, 100 ˚C) for 10 min. Reaction was monitored by TLC,
in which the disappearance of 1a indicated
the completeness of reaction. The mixture was added into H2O
(30 mL) and adjusted to neutrality with the solution of 5% HCl.
Precipitate appeared and was filtered. Finally, 3a (374mg,
72%) was obtained by purifying the precipitate on silica
gel column chromatography (PE 60-90-EtOAc = 2:1); 3s was obtained by the same way, except
that the equivalent of NaOMe (6.0 mmol, 4 equiv) was different when 2b was instead of 2a.
20
Varga M.
Bátori S.
Kövári-Rádkai M.
Prohászka-Német I.
Vitányi-Morvai M.
Böcskey Z.
Bokotey S.
Simon K.
Hermecz I.
Eur. J.
Org. Chem.
2001,
20:
3911